BBlogFlow

Drinking 'Very' Hot Tea or Coffee Could Triple Your Risk of This Cancer, Huge Study Finds - ScienceAlert

·1d ago
Source: ScienceAlert
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Plenty of people like to start their day with a cup of tea or coffee, but the temperature of your preferred beverage could matter a lot more than you realize. A decade ago, the International Agency for Research on Cancer (IARC) made headlines when it classified very hot beverages at temperatures above 65 °C (149 °F) as "probably carcinogenic to humans". That 2016 finding followed evidence that mate, a herbal drink popular in South America and often drunk at very hot temperatures, was associated with an increased risk of esophageal cancer. Mate is typically consumed at temperatures as high as 70 °C (158 °F), but until now, the evidence for hot beverages consumed at cooler temperatures was inconclusive. "International research has shown for some time that drinking beverages like mate at very high temperatures, as is typical in South America, is linked to increased risk of certain esophageal cancers," says nutritional epidemiologist Keren Papier from the University of Oxford. "What was less clear was whether this also applied to the temperatures at which hot drinks are usually consumed in Western populations. "The temperature of hot beverages could matter a lot more than you realize.

This article is an excerpt. To read the full content, visit the original source. ScienceAlert

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·